“The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells”, Swiss Med Wkly, vol. 131, no. 0304, pp. 41–46, Jan. 2001, doi: 10.4414/smw.2001.06144.